- Home
- Site Map
Site Map
- The concept of CMR
- Definition and History
- Interactive Graph
- Historical Perspective
- The Obesity and Type 2 Diabetes Epidemics
- The Epidemiological Evidence
- The Concept of Energy Balance
- Epidemiology
- Traditional Modifiable CVD Risk Factors
- Type 2 Diabetes
- Abdominal Obesity vs CVD: Beyond Body Weight
- Abdominal obesity vs Type 2 Diabetes: Beyond Body Weight
- Intra-abdominal Adipose Tissue: The Culprit?
- Complications of Intra-abdominal Obesity
- Type 2 Diabetes: the Ultimate Manifestation
- Causes and Correlates of Intra-abdominal Obesity
- A Marker of Ectopic Fat Deposition?
- Intra-abdominal Obesity and Cardiometabolic Risk
- Relationship to CVD and Type 2 Diabetes
- Evaluating CMR
- Clinical Tools
- Indices of Total Adiposity
- Waist Circumference Measurement Guidelines
- Waist-to-hip Ratio
- Sagittal Diameter
- Imaging Techniques
- Computed Tomography
- Magnetic Resonance Imaging
- Others
- Assessing CVD Risk: Traditional Approaches
- Framingham
- PROCAM
- Others
- Limitations
- Metabolic Syndrome and Type 2 Diabetes/CVD Risk
- Usefulness of Hypertriglyceridemic Waist
- NCEP-ATP III
- IDF
- Others
- Comparison of Screening Tools
- Limitations
- Assessing Cardiometabolic Risk
- Traditional and Emerging CVD Risk Markers/Factors
- Managing CMR
- Targeting Traditional CVD Risk Factors in Patients with Abdominal Obesity
- CVD
- Lipids
- Hypertension
- Type 2 Diabetes
- Smoking
- Obesity
- Residual Cardiometabolic Risk of Treated Patients
- Evidence from Clinical Trials
- Effects of Weight Loss on Adipose Tissue Distribution
- Effect of Weight Loss on Intra-abdominal Obesity
- Managing CMR in Abdominally Obese Patients
- Nutrition
- Physical Activity and Exercise
- Pharmacotherapy
- Preventing Type 2 Diabetes
- Targeting Abdominal Obesity